Cytek Biosciences, Inc. (CTKB): EBITDA
-$32.80M
Year ended 2025-12-31
-$36.96M
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$32.80M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$13.31M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$21.80M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $688.0K | -93.4% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $10.40M | -27.1% | 2024-03-13, From 2021-01-01 |
| 2020-12-31 | $14.26M | n/a | 2023-03-01, From 2020-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | -$32.80M | n/m |
| Quanterix Corp (QTRX) | 2025-12-31 | -$109.70M | n/m |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | -$24.79M | n/m |
| 908 Devices Inc. (MASS) | 2025-12-31 | -$34.96M | n/m |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | -$44.14M | n/m |
| EyePoint, Inc. (EYPT) | 2025-12-31 | -$241.12M | n/m |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | -$23.81M | n/m |
| Precipio, Inc. (PRPO) | 2025-12-31 | $43.0K | n/m |
| Seer, Inc. (SEER) | 2025-12-31 | -$72.87M | n/m |
Compare CTKB, QTRX, TXG, MASS side by side · Screen every company in Laboratory Analytical Instruments ↗